EDGEWISE THERAPEUTICS INC (EWTX) Stock Income Statement
NASDAQ:EWTX - Nasdaq - US28036F1057 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 170.04M | 158.83M | 114.36M | 71.66M | 43.22M | |||
| Research and Development | 136.03M | 126.97M | 90.91M | 54.03M | 32.19M | |||
| Selling, General, and Administrative Expenses | 34.01M | 31.87M | 23.45M | 17.63M | 11.03M | |||
| Operating Income | -170.04M | -158.83M | -114.36M | -71.66M | -43.22M | |||
| Interest Income/Expense | 23.95M | 25.02M | 14.19M | 4.02M | 400.00K | |||
| Income Before Taxes | -146.09M | -133.81M | -100.16M | -67.64M | -42.81M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -146.09M | -133.81M | -100.16M | -67.64M | -42.81M | |||
| EBITDA | -167.67M | -156.54M | -112.63M | -71.29M | -42.95M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.55 | -1.45 | -1.57 | -1.26 | -1.14 | |||
| Non GAAP EPS | -1.55 | -1.45 | -1.58 | -1.27 | -0.87 | |||
| Statistics | ||||||||
All data in USD